Navigation Links
Group proves it's possible to grow new lung alveoli by growing new blood vessels

The good news is that medical advances in perinatal care have allowed us to save many more premature babies. The bad news is they're often at risk of developing bronchopulmonary dysplasia--a chronic lung disease caused by having to place the tiny infants on ventilators and oxygen-rich therapy for acute respiratory failure.

It's really a win-lose situation: the babies are saved but they pay the price with dramatically underdeveloped lungs--forcing them to spend their early days outside the womb fighting for every breath. And now, with many of these premature babies reaching their adolescent years, clinicians and researchers are also waiting to see whether longer term health problems are going to begin occurring.

"Right now we simply don't have any treatments," says Bernard Thébaud, a clinician-scientist and neonatologist in the Department of Pediatrics. "So, if we can't prevent it, we've started to think about how we might repair it."

Using animal models, Dr. Thébaud and a team of University of Alberta researchers have taken what they say is the first important step towards a treatment--in effect, growing new blood vessels and alveoli--the tiny air sacs where gas exchange occurs between the lungs and blood vessels--in tiny rat lungs.

The results of their work were recently published in Circulation, entitled Vascular Endothelial Growth Factor Gene Therapy Increases Survival, Promotes Lung Angiogenesis, and Prevents Alveolar Damage in Hyperoxia-Induced Lung Injury: Evidence That Angiogenesis Participates in Alveolarization.

The results have caused a stir in the scientific community: In an accompanying editorial in the October 18 issue of the journal, Kurt Stenmark, a University of Colorado Divisions of Critical Care and Pulmonary Medicine researcher, said the studies "…raise new possibilities for the treatment of infants with severe chronic lung disease. It seems possible that by augmenting or restoring vascular growth, overall lu ng growth and ultimately lung function can be restored."

Doing that involved a new gene therapy technique, explains Dr. Thébaud. Knowing that a particular protein, VEGF, a vascular endothelial growth factor, is crucial for the normal development of the lung, and that angiopoeitin-1, another angiogenic growth factor is crucial for blood vessel maturation, the team attached the proteins to an adenovirus and administered it through an aerosol directly into the lungs. In effect, the virus carried the protein to the heart of millions of lung cells. Once inside the cells, the growth factor proteins went to work doing the job they were programmed to do.

The results were striking: In microscopic images, the scientists have charted the growth of alveoli and lung capillaries. In a typically healthy lung, a complex network of capillaries encircles the alveoli. Oxygen flows from the lungs through ultra-fine epithelial and endothelial tissues into the blood; carbon dioxide diffuses from the blood into the alveoli. In an infant's underdeveloped lungs, the alveoli are larger and fewer and there are fewer developed capillaries. It's a condition that leaves them gasping--and one that is shared by people who have emphysema.

"At this stage it's simply proof of principle," says Dr. Thébaud, also a pediatrician at the Stollery Children's Hospital's Neonatal Intensive Care Unit. The next step is to prove it's possible to replicate safely in larger mammals. Once that's done, it's possible the concept--growing blood vessels to cure a disease that is traditionally thought of as an airway disease--could be tested clinically in people.


Source:University of Alberta

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
3. Purdue proves concept of using nano-materials for drug discovery
4. FDA Approves New Drug to Treat Type I and Type II Diabetes
5. Canada approves marijuana-based pain spray
6. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
7. Product improves peptide identification for proteomics research
8. FDA Approves New Treatment for Chronic Hepatitis B
9. Stem cell treatment improves mobility after spinal cord injury
10. FDA approves more generic AIDS drugs
11. Experimental shingles vaccine proves effective in nationwide study
Post Your Comments:

(Date:11/16/2015)... , Nov 16, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced expansion of its TDDI ... touch controller and display driver integration (TDDI) ... smartphones. These new TDDI products add to the ... resolution), TD4302 (WQHD resolution), and TD4322 (FHD resolution) ...
(Date:11/12/2015)... LONDON , Nov. 11, 2015   ... and reliable analytical tools has been paving the ... and qualitative determination of discrete analytes in clinical, ... sensors are being predominantly used in medical applications, ... and environmental sectors due to continuous emphasis on ...
(Date:11/10/2015)... About signature verification Signature ... identify and verify the identity of an individual ... secure and accurate method of authentication and is ... because each individual,s signature is highly unique. Signature ... signature of an individual is compared and matched ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, December ... Helen Torley , president and CEO, will provide a corporate overview. ... New York at 1:00 p.m. ET/10:00 a.m. PT . ... investor relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... Global, Inc., a worldwide provider of clinical research services headquartered in ... company has set a new quarterly earnings record in Q3 of ... for Q3 of 2014 to Q3 of 2015.   ... with the establishment of an Asia-Pacific office ... Kingdom and Mexico , with the ...
(Date:11/24/2015)... , November 24, 2015 ... recent market research report released by Transparency Market Research, ... expand at a CAGR of 17.5% during the period ... Testing Market - Global Industry Analysis, Size, Volume, Share, ... global non-invasive prenatal testing market to reach a valuation ...
(Date:11/24/2015)... ... November 24, 2015 , ... InSphero AG, the leading supplier of easy-to-use ... promoted Melanie Aregger to serve as Chief Operating Officer. , Having joined ... management team and was promoted to Head of InSphero Diagnostics in 2014. ...
Breaking Biology Technology: